Drug development. Drugs inspired by a drug.
Marx
Jean
J
D000818:Animals; D019440:Anti-Obesity Agents / Q000627:therapeutic use; D001007:Anxiety / Q000188:drug therapy; D001095:Arachidonic Acids / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use; D001794:Blood Pressure / Q000187:drug effects; D001921:Brain / Q000187:drug effects; D063387:Cannabinoid Receptor Antagonists; D063385:Cannabinoid Receptor Modulators / Q000819:agonists / Q000037:antagonists & inhibitors / Q000494:pharmacology / Q000502:physiology*; D018849:Controlled Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical; D063388:Endocannabinoids; D006801:Humans; D007249:Inflammation / Q000188:drug therapy; D009474:Neurons / Q000187:drug effects; D009765:Obesity / Q000188:drug therapy; D010024:Osteoporosis / Q000188:drug therapy; D010146:Pain / Q000188:drug therapy; D010880:Piperidines / Q000494:pharmacology / Q000627:therapeutic use*; D053284:Polyunsaturated Alkamides; D011720:Pyrazoles / Q000494:pharmacology / Q000627:therapeutic use*; D043882:Receptors, Cannabinoid / Q000502:physiology*; D000077285:Rimonabant; D016540:Smoking Cessation
D019440:Anti-Obesity Agents; D001095:Arachidonic Acids; D063387:Cannabinoid Receptor Antagonists; D063385:Cannabinoid Receptor Modulators; D063388:Endocannabinoids; D010880:Piperidines; D053284:Polyunsaturated Alkamides; D011720:Pyrazoles; D043882:Receptors, Cannabinoid; D000077285:Rimonabant; C078814:anandamide